tradingkey.logo
tradingkey.logo

Acumen Pharmaceuticals Announces $35.75 Million Private Placement To Advance Potential Best-In-Class Molecules From Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio

ReutersMar 16, 2026 10:38 AM

- Acumen Pharmaceuticals Inc ABOS.O:

  • ACUMEN PHARMACEUTICALS ANNOUNCES $35.75 MILLION PRIVATE PLACEMENT TO ADVANCE POTENTIAL BEST-IN-CLASS MOLECULES FROM AMYLOID BETA OLIGOMER-SELECTIVE ENHANCED BRAIN DELIVERY PORTFOLIO

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI